Literature DB >> 26585883

Engineering and characterization of simplified vaginal and seminal fluid simulants.

Rachna Rastogi1, Jonathan Su2, Alamelu Mahalingam1, Justin Clark2, Samuel Sung2, Thomas Hope3, Patrick F Kiser4.   

Abstract

BACKGROUND: Reported vaginal and seminal fluid simulants have complex compositions with multiple preparatory steps that contribute to physical instability. We report the design and characterization of stable and simplified buffers that mimic the salient physical/chemical properties of the physiological fluids. STUDY DESIGN/
METHODS: Human cervicovaginal and seminal fluid samples were collected and buffering capacity was determined. The major buffering species were identified from published compositions of reproductive tract fluids. These values were used to compute the composition of vaginal and seminal fluid simulants. Ionic strength, buffering capacities, pH and osmolalities were then calculated or experimentally determined. Finally, cytotoxicity was evaluated in HEC-1-A cells and 3D reconstructed EpiVaginal™ tissue (VEC-100-FT) using naïve cells/tissue and nonoxynol-9 as controls.
RESULTS: The use of calculated amounts of conjugate acid and base for buffer development resulted in compositions that did not require endpoint pH adjustment and could be formulated as stable 10× concentrates. Furthermore, due to the absence of complex divalent salts, all our proposed simulants were stable at 4 °C for 1 month whereas precipitation and pH and osmolality changes were noted in reported buffers. Experimental determination of buffering capacities yielded similar values for undiluted cervicovaginal fluid (β4.2-5.2=35.6 ± 12.3 mM, N=7) and human seminal fluid (β7-6=37.5 ± 5 mM, N=3). All neat simulants showed significant cytotoxicity in HEC-1-A cells but were well tolerated by organotypic vaginal tissue.
CONCLUSIONS: We report revised and improved compositions of buffers mimicking salient properties of vaginal and seminal fluid necessary for in vitro product evaluation. IMPLICATIONS: To support research in reproductive health and in particular drug delivery, we have designed and characterized stable new media to mimic these important fluids that can be used in a variety of in vitro studies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buffering capacity; Cytotoxicity; Human cervicovaginal fluid; Simulant design

Mesh:

Substances:

Year:  2015        PMID: 26585883      PMCID: PMC4863460          DOI: 10.1016/j.contraception.2015.11.008

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  18 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

2.  Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women.

Authors:  Caroline Mitchell; Kathleen Paul; Kathy Agnew; Reggie Gaussman; Robert W Coombs; Jane Hitti
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

Review 3.  Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.

Authors:  Sanjay Garg; David Goldman; Markus Krumme; Lisa C Rohan; Stuart Smoot; David R Friend
Journal:  Antiviral Res       Date:  2010-12       Impact factor: 5.970

4.  Defined medium simulating genital tract secretions for growth of vaginal microflora.

Authors:  A M Geshnizgani; A B Onderdonk
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 5.  A review of the physical and chemical properties of human semen and the formulation of a semen simulant.

Authors:  Derek H Owen; David F Katz
Journal:  J Androl       Date:  2005 Jul-Aug

Review 6.  Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms.

Authors:  J B Dressman; G L Amidon; C Reppas; V P Shah
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

7.  Continuous measurement by radio-telemetry of vaginal pH during human coitus.

Authors:  C A Fox; S J Meldrum; B W Watson
Journal:  J Reprod Fertil       Date:  1973-04

8.  In vivo semen-associated pH neutralization of cervicovaginal secretions.

Authors:  C Tevi-Bénissan; L Bélec; M Lévy; V Schneider-Fauveau; A Si Mohamed; M C Hallouin; M Matta; G Grésenguet
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

9.  A practical approach for acid-base characterization of human semen.

Authors:  R L Searcy; N M Simms
Journal:  Int J Fertil       Date:  1967 Jul-Sep

10.  Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs.

Authors:  E Galia; E Nicolaides; D Hörter; R Löbenberg; C Reppas; J B Dressman
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

View more
  6 in total

1.  The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans.

Authors:  Jacklyn Johnson; Manuel G Flores; John Rosa; Changze Han; Alicia M Salvi; Kris A DeMali; Jennifer R Jagnow; Amy Sparks; Hillel Haim
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

2.  Comparative genome analyses of Lactobacillus crispatus isolated from different ecological niches reveal an environmental adaptation of this species to the human vaginal environment.

Authors:  Leonardo Mancabelli; Walter Mancino; Gabriele Andrea Lugli; Christian Milani; Alice Viappiani; Rosaria Anzalone; Giulia Longhi; Douwe van Sinderen; Marco Ventura; Francesca Turroni
Journal:  Appl Environ Microbiol       Date:  2021-02-12       Impact factor: 4.792

Review 3.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

4.  Comparative Analysis of Lactobacillus gasseri and Lactobacillus crispatus Isolated From Human Urogenital and Gastrointestinal Tracts.

Authors:  Meichen Pan; Claudio Hidalgo-Cantabrana; Yong Jun Goh; Rosemary Sanozky-Dawes; Rodolphe Barrangou
Journal:  Front Microbiol       Date:  2020-01-22       Impact factor: 5.640

5.  Clinical Candida albicans Vaginal Isolates and a Laboratory Strain Show Divergent Behaviors during Macrophage Interactions.

Authors:  Franziska Gerwien; Christine Dunker; Philipp Brandt; Enrico Garbe; Ilse D Jacobsen; Slavena Vylkova
Journal:  mSphere       Date:  2020-08-19       Impact factor: 4.389

6.  Segmented intravaginal ring for the combination delivery of hydroxychloroquine and anti-CCR5 siRNA nanoparticles as a potential strategy for preventing HIV infection.

Authors:  Yannick L Traore; Yufei Chen; Fernanda Padilla; Emmanuel A Ho
Journal:  Drug Deliv Transl Res       Date:  2021-04-17       Impact factor: 4.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.